Early disease progression in patients with localized natural killer/T‐cell lymphoma treated with concurrent chemoradiotherapy

Prognosis of patients with localized nasal extranodal natural killer/T‐cell lymphoma, nasal type (ENKL) has been improved by non‐anthracycline‐containing treatments such as concurrent chemoradiotherapy (CCRT). However, some patients experience early disease progression. To clarify the clinical featu...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaguchi, Motoko, Suzuki, Ritsuro, Kim, Seok Jin, Ko, Young Hyeh, Oguchi, Masahiko, Asano, Naoko, Miyazaki, Kana, Terui, Yasuhiko, Kubota, Nobuko, Maeda, Takeshi, Kobayashi, Yukio, Amaki, Jun, Soejima, Toshinori, Saito, Bungo, Shimoda, Emiko, Fukuhara, Noriko, Tsukamoto, Norifumi, Shimada, Kazuyuki, Choi, Ilseung, Utsumi, Takahiko, Ejima, Yasuo, Kim, Won Seog, Katayama, Naoyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989836/
https://www.ncbi.nlm.nih.gov/pubmed/29601137
http://dx.doi.org/10.1111/cas.13597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989836/
https://www.ncbi.nlm.nih.gov/pubmed/29601137
http://dx.doi.org/10.1111/cas.13597

Ejemplares similares